| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/06/2023 | 25.17% | Keybanc | $102 → $91 | Maintains | Overweight |
| 10/13/2023 | 10.04% | Citigroup | $85 → $80 | Maintains | Neutral |
| 10/11/2023 | 1.79% | B of A Securities | $100 → $74 | Downgrades | Neutral → Underperform |
| 09/13/2023 | 33.43% | Stifel | → $97 | Reiterates | Buy → Buy |
| 08/30/2023 | 16.92% | Citigroup | $100 → $85 | Maintains | Neutral |
| 07/21/2023 | 37.55% | B of A Securities | $88 → $100 | Downgrades | Buy → Neutral |
| 07/17/2023 | 37.55% | Citigroup | $95 → $100 | Downgrades | Buy → Neutral |
| 06/26/2023 | 33.43% | Oppenheimer | $90 → $97 | Maintains | Outperform |
| 05/10/2023 | 30.67% | Citigroup | $98 → $95 | Maintains | Buy |
| 05/09/2023 | 14.17% | Evercore ISI Group | $89 → $83 | Maintains | Outperform |
| 03/06/2023 | 44.43% | Jefferies | $95 → $105 | Maintains | Buy |
| 02/08/2023 | 34.8% | Citigroup | $78 → $98 | Maintains | Buy |
| 02/08/2023 | 8.67% | Goldman Sachs | $70 → $79 | Maintains | Neutral |
| 02/07/2023 | 21.05% | Morgan Stanley | $83 → $88 | Maintains | Equal-Weight |
| 02/07/2023 | 23.8% | Oppenheimer | $88 → $90 | Maintains | Outperform |
| 02/07/2023 | 40.3% | Keybanc | $88 → $102 | Maintains | Overweight |
| 01/23/2023 | 21.05% | Oppenheimer | $84 → $88 | Maintains | Outperform |
| 01/13/2023 | 19.67% | B of A Securities | $71 → $87 | Upgrades | Neutral → Buy |
| 12/19/2022 | 16.92% | Stifel | $81 → $85 | Maintains | Buy |
| 12/15/2022 | -3.71% | Goldman Sachs | $62 → $70 | Maintains | Neutral |
| 12/14/2022 | 14.17% | Morgan Stanley | $70 → $83 | Maintains | Equal-Weight |
| 11/21/2022 | 21.05% | Keybanc | $75 → $88 | Maintains | Overweight |
| 10/27/2022 | -3.71% | Morgan Stanley | $69 → $70 | Maintains | Equal-Weight |
| 10/13/2022 | -5.09% | Morgan Stanley | $68 → $69 | Maintains | Equal-Weight |
| 09/30/2022 | 10.04% | Oppenheimer | $77 → $80 | Maintains | Outperform |
| 08/01/2022 | -6.46% | Morgan Stanley | $63 → $68 | Maintains | Equal-Weight |
| 07/18/2022 | -13.34% | Morgan Stanley | $70 → $63 | Maintains | Equal-Weight |
| 07/15/2022 | 3.16% | Jefferies | $85 → $75 | Maintains | Buy |
| 05/03/2022 | 3.16% | Keybanc | $84 → $75 | Maintains | Overweight |
| 04/18/2022 | -0.96% | Morgan Stanley | $76 → $72 | Maintains | Equal-Weight |
| 04/14/2022 | 3.16% | Oppenheimer | → $75 | Initiates Coverage On | → Outperform |
| 04/07/2022 | -11.97% | Goldman Sachs | $74 → $64 | Maintains | Neutral |
| 02/15/2022 | 7.29% | Evercore ISI Group | → $78 | Upgrades | In-Line → Outperform |
| 01/07/2022 | 16.92% | B of A Securities | $80 → $85 | Downgrades | Buy → Neutral |
| 12/13/2021 | 0.41% | Goldman Sachs | $84 → $73 | Downgrades | Buy → Neutral |
| 10/13/2021 | 4.54% | Morgan Stanley | $84 → $76 | Maintains | Equal-Weight |
| 09/27/2021 | 15.54% | Keybanc | $95 → $84 | Maintains | Overweight |
| 09/23/2021 | -0.96% | Loop Capital | → $72 | Initiates Coverage On | → Hold |
| 09/16/2021 | 37.55% | Jefferies | $110 → $100 | Maintains | Buy |
| 08/09/2021 | 15.54% | Morgan Stanley | $91 → $84 | Maintains | Equal-Weight |
| 05/03/2021 | 25.17% | Morgan Stanley | $87 → $91 | Maintains | Equal-Weight |
| 04/29/2021 | 30.67% | Keybanc | $90 → $95 | Maintains | Overweight |
| 04/12/2021 | 19.67% | Morgan Stanley | $90 → $87 | Maintains | Equal-Weight |
| 01/22/2021 | 23.8% | Morgan Stanley | $82 → $90 | Maintains | Equal-Weight |
| 01/14/2021 | 23.8% | KeyBanc | $85 → $90 | Maintains | Overweight |
| 12/15/2020 | 12.79% | Morgan Stanley | $64 → $82 | Maintains | Equal-Weight |
| 11/25/2020 | 19.67% | B of A Securities | $76 → $87 | Maintains | Buy |
| 11/13/2020 | 16.92% | Keybanc | $68 → $85 | Maintains | Overweight |
| 10/30/2020 | -11.97% | Morgan Stanley | $60 → $64 | Maintains | Equal-Weight |
| 10/12/2020 | -17.47% | Morgan Stanley | $55 → $60 | Maintains | Equal-Weight |
| 08/20/2020 | -6.46% | Keybanc | $60 → $68 | Maintains | Overweight |
| 08/04/2020 | -24.35% | Morgan Stanley | $42 → $55 | Maintains | Equal-Weight |
| 08/04/2020 | -17.47% | Keybanc | $55 → $60 | Maintains | Overweight |
| 05/04/2020 | -42.23% | Morgan Stanley | $43 → $42 | Maintains | Equal-Weight |
| 03/30/2020 | -24.35% | Keybanc | $70 → $55 | Maintains | Overweight |
| 03/24/2020 | -38.1% | Morgan Stanley | $48 → $45 | Maintains | Equal-Weight |
| 03/17/2020 | -33.98% | Morgan Stanley | $59 → $48 | Maintains | Equal-Weight |
| 02/06/2020 | -18.84% | Morgan Stanley | $57 → $59 | Maintains | Equal-Weight |
| 01/07/2020 | — | B of A Securities | Upgrades | Underperform → Buy | |
| 12/13/2019 | -11.97% | Stifel | $58 → $64 | Maintains | Buy |
| 12/13/2019 | -21.6% | Morgan Stanley | $52 → $57 | Maintains | Equal-Weight |
| 12/13/2019 | -3.71% | Keybanc | $60 → $70 | Maintains | Overweight |
| 12/10/2019 | -27.1% | B of A Securities | $50 → $53 | Reiterates | → Underperform |
| 11/01/2019 | -28.47% | Morgan Stanley | $50 → $52 | Maintains | Equal-Weight |
| 09/26/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 07/16/2019 | -22.97% | Goldman Sachs | $55 → $56 | Upgrades | Neutral → Buy |
| 06/10/2019 | -25.72% | Morgan Stanley | → $54 | Initiates Coverage On | → Equal-Weight |
| 12/03/2018 | -31.22% | B of A Securities | $45 → $50 | Upgrades | Neutral → Buy |
What is the target price for Timken (TKR)?
The latest price target for Timken (NYSE: TKR) was reported by Keybanc on November 6, 2023. The analyst firm set a price target for $91.00 expecting TKR to rise to within 12 months (a possible 25.17% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Timken (TKR)?
The latest analyst rating for Timken (NYSE: TKR) was provided by Keybanc, and Timken maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Timken (TKR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Timken, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Timken was filed on November 6, 2023 so you should expect the next rating to be made available sometime around November 6, 2024.
Is the Analyst Rating Timken (TKR) correct?
While ratings are subjective and will change, the latest Timken (TKR) rating was a maintained with a price target of $102.00 to $91.00. The current price Timken (TKR) is trading at is $72.70, which is out of the analyst's predicted range.